Effect of Antiplatelets in Diabetic Peripheral Vasculopathy: Comparison by Ankle-Brachial Index and Peak Wave Velocity

명, 유병률은 10.1%에 달하며 2050년에는 당뇨병 환자수가 약 6백 만 명으로 증가할 것으로 예상된다고 한다. 당뇨병 환자의 수가 증 가함에 따라 당뇨병에 의한 합병증을 가진 환자 또한 빠르게 증가 하고 있는데, 대표적인 합병증 중 하나가 당뇨병성 족부 질환이다. 당뇨병성 족부 질환은 여러 가지 요인에 의해 발생하나 중요한 원 인 인자 중에 하나가 바로 당뇨병성 말초혈관병증이다. 당뇨병성 말초혈관병증을 치료하기 위해 많은 다양한 치료 방법 이 시도되고 있으나 그 가운데 가장 흔히 사용되는 방법은 항혈소 판제 복용이다. 하지만, 항혈소판제에 대한 명확한 사용 지침은 아 직까지 없다. 또한, 항혈소판제의 치료 및 예방 효과에 있어서도 논란이 지속되고 있으며, 병용 요법의 유용성에 대해서도 논란이 있다. 최근 국내에서는 항혈소판제 병용 요법의 출혈 경향과 관 련된 합병증의 증가 및 비용에 관한 우려로 사용이 제한되기도 하 서 론

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  2014-12-01

• Fields of study

  Medicine, Physics

• Identifiers
  DOI 10.14193/JKFAS.2014.18.4.159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes

  2012cited by this paper
• Developing and Validating a Risk Score for Lower-Extremity Amputation in Patients Hospitalized for a Diabetic Foot Infection

  2011cited by this paper
• Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.

  2011cited by this paper
• Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions

  2009cited by this paper
• asymptomatic peripheral arterial disease and antioxidants in patients with diabetes and randomised placebo controlled trial of aspirin factorial disease and diabetes (POPADAD) trial: The prevention of progression of arterial

  2008cited by this paper
• Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.

  2007cited by this paper
• Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.

  2006cited by this paper
• Noninvasive diagnostic strategies for peripheral arterial disease.

  2006cited by this paper
• Sarpogrelate, a 5-HT2A receptor antagonist in intermittent claudication. A Phase II European study

  2006cited by this paper
• Preventing foot ulcers in patients with diabetes

  2005cited by this paper
• Randomized clinical trial of the antiplatelet effects of aspirin–clopidogrel combination versus aspirin alone after lower limb angioplasty

  2005cited by this paper
• Effect of the Serotonin Blocker Sarpogrelate on Circulating Interleukin-18 Levels in Patients with Diabetes and Arteriosclerosis Obliterans

  2004cited by this paper
• Effects of Cilostazol on Platelet Activation in Coronary Stenting Patients Who Already Treated with Aspirin and Clopidogrel.

  2004cited by this paper
• The platelet in diabetes: focus on prevention of ischemic events.

  2003cited by this paper
• Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus.

  2002cited by this paper
• Assessment of arterial stiffness in clinical practice.

  2002cited by this paper
• TBI or not TBI: that is the question. Is it better to measure toe pressure than ankle pressure in diabetic patients?

  2001cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

  1996cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

  1996cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

  1996cited by this paper
• Lower extremity foot ulcers and amputations in diabetes

  1995cited by this paper
• Serotonin‐stimulated aortic endothelial cells secrete a novel T lymphocyte chemotactic and growth factor

  1994cited by this paper
• Effects of the anti-platelet agent cilostazol on peripheral vascular disease in patients with diabetes mellitus.

  1992cited by this paper
• Trial of repeated low-dose aspirin in diabetic angiopathy.

  1986cited by this paper
• Veterans Administration Cooperative Study on Antiplatelet Agents in Diabetic Patients After Amputation for Gangrene: II. Effects of Aspirin and Dipyridamole on Atherosclerotic Vascular Disease Rates

  1986cited by this paper
• Thermographic evaluation of the hemodynamic effect of the antithrombotic drug cilostazol in peripheral arterial occlusion.

  1985cited by this paper
• AN EFFECT OF D-GLUCOSE ON PLATELET STICKINESS.

  1965cited by this paper
• Children's Clinic, Helsinki.

  1948cited by this paper

• No citing papers are available for this paper.